Figure][1] Michael Teitell, MD, PhD Dr. Michael Teitell is the director of the UCLA Health Jonsson Comprehensive Cancer ...

Radiopharmaceutical therapy (RPT) offers molecular-targeted treatment strategies and presents an ideal model for advancing ...

There are no established treatment options for patients with meningioma recurring after surgery and radiotherapy.

Irène Buvat, PhD, Centre National de la Recherche Scientifique director of research and head of the Inserm Laboratory of Translational Imaging in Oncology at the Institut Curie, Orsay (France), and ...

Noncollimated high-sensitivity SPECT was developed by Mitchell and Cherry (6) using 2 closely spaced scintillator detectors. This approach allows a high (40%) detection efficiency to be reached but ...

Journal of Nuclear Medicine December 2025, jnumed.125.271365; DOI: https://doi.org/10.2967/jnumed.125.271365 ...

Journal of Nuclear Medicine December 2025, jnumed.125.270792; DOI: https://doi.org/10.2967/jnumed.125.270792 ...

TO THE EDITOR: In the article written by Veit-Haibach et al. (1), the authors highlight the growing interest in the use of radiopharmaceuticals for both diagnosis and treatment, with a significant ...

The subjects of this study were those who underwent conventional wbPET imaging for clinical examination, for free medical treatment, or as part of the Japan Agency for Medical Research and Development ...

Thyroid nodules (TN) are commonly encountered in clinical practice, with a prevalence ranging between 20% and 60% in prospective, randomly selected patients (1–3). Although some may cause local ...

Prostate cancer screening currently consists of serum prostate-specific antigen and digital rectal examination, followed by transrectal ultrasound-guided biopsy for diagnostic confirmation. Although ...

Biochemical recurrence (BCR) after radical prostatectomy occurs in up to 40% of prostate cancer patients (1). Salvage radiotherapy (sRT) is recommended as the main curative option for patients with ...